Study cohort (n = 99) | |
---|---|
Age (years) (mean (median:IQR)) | 65.9 (66 : 62.0-69.0) |
PSA (ng/mL) (mean (median:IQR)) | 46.1 (7.4 : 5.5-11.6)a |
Family history of PCa (no-yes-NA) | 43.4%-13.1%-42.4% |
First biopsy (n (%)) | 91 (92.0%) |
Prostate volume (mean (median:IQR)) | 55.5 (49: 36-72) |
PSA density (ng/mL x cc-1) (mean (median : IQR)) | 0.89 (0.15 : 0.09-0.27) |
DRE (abnormal) (%) | 54 (54.5%) |
PCa diagnosis (n (%)) | 54 (54.5%) |
Gleason score ≤6 (n (%)) | 17 (31.5%) |
Gleason score 7 (n (%)) | 18 (33.3%) |
Gleason score 8-10 (n (%)) | 19 (35.2%) |